The Difference Between Access on Paper and Access in Practice

Understand why specialty drug access breaks down after coverage is approved and how employers can close the gap between coverage and care.

Behind Every Claim Is a Person: Why Prescription Care Needs a Different Playbook in 2026

If you spend your days looking at pharmacy trend reports and renewal spreadsheets, it is easy to forget what those numbers really represent.

The Hidden Driver of Employee Experience (and Retention): Human-Led Care Guides

Human-led Care Guides reduce friction in complex medication moments, helping employees start and stay on therapy. The result: better experience, higher confidence, and stronger retention for employers.

The Yardstick That Matters: Redefining Outcomes in Prescription Care

Outcomes don’t improve by accident. Better processes, faster therapy access, and clear guidance are the foundation of patient-centered prescription care—and the new standard employers should expect.

Formulary design that captures the savings (without disruption)

Rebates don’t equal value. Here’s how to align to net cost, enable substitution, and keep your people on track.

Biosimilars: What HR Leaders Need to Know in 5 Minutes

If we had five minutes between meetings, here’s what I’d share: biosimilars are no longer a maybe. They’re a practical way to protect your budget and keep care steady for your people.

GLP-1s in 2026: Fund Access, Protect Outcomes, Avoid the Blank Check

If you manage employer benefits, you’re staring at a 2026 puzzle: demand for GLP-1 medications keeps climbing while prices remain elevated, and oral options may expand utilization further.

The Silent Surge Driving Pharmacy Costs — and How to Stop It

Right now, there’s a storm brewing in specialty drug trend—and most plan sponsors don’t even see it coming. If you’re focused